Justice Department, Antitrust Division
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Justice Antitrust Division Notice is hereby given that, on September 23, 2003, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (“the Act”), Biotechnology Research and Development Corporation (“BRDC”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, PIC International PLC, San Francisco, CA has changed its name to Sygen International PLC; and American Home Products Corporation, Parsippany, NJ has changed its name to Wyeth. Also, Schering-Plough Animal Health Corporation, Madison, NJ; Baxcare Health Corporation, Round Lake, Il; Maxygen, Inc., Santa Clara, CA; and Alexion Pharmaceuticals, Inc., New Haven, CT are no longer parties to BRDC. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and BRDC intends to file additional written notification disclosing all changes in membership. On April 13, 1988, BRDC filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on May 12, 198…
Citation: 68 FR 59197
